Today: 12 June 2026
Browse Category

NASDAQ:ASBP 11 November 2025 - 15 December 2025

Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching

Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching

Aspire Biopharma shares fell about 8% to $0.095 on December 15, 2025, as the company’s stock transferred from the Nasdaq Global Select Market to the Nasdaq Capital Market. Aspire faces Nasdaq deadlines to regain compliance with minimum bid price and equity rules by early 2026. The company is also advancing an FDA regulatory milestone for its sublingual aspirin program.
15 December 2025
·
Aspire Biopharma (ASBP) Jumps on $100M Equity Line and Q3 Filing – What Matters on November 14, 2025

Aspire Biopharma (ASBP) Jumps on $100M Equity Line and Q3 Filing – What Matters on November 14, 2025

Aspire Biopharma Holdings (NASDAQ: ASBP) surged over 30% in pre-market trading Friday after announcing a new $100 million equity line of credit with Arena Business Solutions and releasing its Q3 2025 10-Q. Shares traded around $0.14, up from Thursday’s $0.11 close, with market cap near $5.3 million. The new deal replaces a prior ELOC signed in February.
14 November 2025
·
Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025

Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025

ASBP shares dropped roughly 20–25% mid-session Nov. 11, trading on heavy volume and swinging between $0.1189 and $0.2471. No new company news was released; the last updates were last week’s CPHI Frankfurt partnering recap and special meeting results. Nasdaq delisting risk remains after Aspire requested a hearing to contest compliance failures.
11 November 2025
·

Stock Market Today

  • SpaceX Prices Record IPO Potentially Making Elon Musk a Trillionaire
    June 11, 2026, 6:44 PM EDT. SpaceX confirmed its initial public offering (IPO) priced at $135 per share, valuing the company near $1.8 trillion. The IPO will raise a record $75 billion, surpassing Saudi Aramco's $29.4 billion debut as the largest ever. Underwriters may buy an additional 83 million shares, potentially increasing proceeds to $86 billion. The company's valuation now exceeds Tesla, Meta, and Walmart, placing it among Wall Street's top 10 companies. SpaceX will trade on the Nasdaq under the ticker "SPCX" with a parallel listing on Nasdaq Texas. Market watchers will monitor the IPO's impact on global markets and Musk's potential leap to trillionaire status.

Latest articles

AST SpaceMobile Jumps After BlueBird Launch Date News

AST SpaceMobile Jumps After BlueBird Launch Date News

12 June 2026
AST SpaceMobile shares soared 11.73% to $97.56 after confirming BlueBird satellites 8, 9, and 10 will launch June 17 on a Falcon 9, aiming to nearly double peak data speeds for its direct-to-smartphone broadband network; shares reached $101.00 after hours as investors focused on this key deployment milestone following recent volatility.
Sandisk Jumps to 52-Week High, Gains 14.5% in AI-Fueled Push

Sandisk Jumps to 52-Week High, Gains 14.5% in AI-Fueled Push

12 June 2026
Sandisk soared 14.5% to $1,881.51 after hitting a 52-week high amid a semiconductor rally, fueled by a 251% year-over-year revenue jump and bullish guidance for Q4 revenue of $7.75–$8.25 billion; Bank of America raised its price target to $2,100, citing strong memory pricing and supply contracts, as Sandisk joins the Nasdaq-100 and investors eye data-center demand and new business agreements.
Go toTop